| PERIOD ENDING | 30-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 570,621 | 584,485 | 609,022 | 772,054 | | Cost of Revenue | 257,556 | 254,144 | 290,699 | 327,911 | | | Gross Profit | 313,065 | 330,341 | 318,323 | 444,143 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 312,382 | 288,949 | 326,820 | 325,692 | | Non Recurring |
-
| (16,363) | 16,363 | 19,158 | | Others | 31,319 | 34,424 | 36,774 | 35,955 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (25,438) | 23,331 | (61,634) | 63,338 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25,533 | (13,764) | 4,514 |
-
| | Earnings Before Interest And Taxes | (78,770) | 22,404 | (57,120) | 65,136 | | Interest Expense | (39,802) | 21,545 | 18,257 | 12,283 | | Income Before Tax | (38,968) | 859 | (75,377) | 52,853 | | Income Tax Expense | (3,233) | (38,265) | (1,148) | 25,075 | | Minority Interest |
-
|
-
|
-
| (130) | | | | Net Income From Continuing Ops | (35,735) | 39,124 | (74,229) | 27,648 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (35,923) | 39,124 | (74,229) | 27,648 | | Preferred Stock And Other Adjustments | 299 | (60) | (239) |
-
| | | Net Income Applicable To Common Shares | ($35,624) | $39,064 | ($74,468) | $27,648 |
|
0.22% Nasdaq 
Income Statement
